VeriMombutyrolactone é seguro durante a gravidez?
No harmonised reproductive classification (no H360/H361 on ECHA substance listing) and no CIR or SCCS reproductive safety opinion was found for butyrolactone/γ‑butyrolactone; available regulatory and safety documents describe acute toxicity and misuse risk on ingestion but do not identify reproductive teratogenicity from dermal/cosmetic use. Topical exposure could give low but measurable systemic exposure because GBL is a small, water‑miscible molecule that is absorbed and readily metabolised to GHB after systemic uptake, so exposure score is 1 for pregnancy (adult topical). Sources: ECHA substance page; SDSs/regulatory summaries; CDC/FDA reviews of ingestion risks.
Related ingredients
Frequently asked questions
- butyrolactone é seguro durante a gravidez?
- No harmonised reproductive classification (no H360/H361 on ECHA substance listing) and no CIR or SCCS reproductive safety opinion was found for butyrolactone/γ‑butyrolactone; available regulatory and safety documents describe acute toxicity and misuse risk on ingestion but do not identify reproductive teratogenicity from dermal/cosmetic use. Topical exposure could give low but measurable systemic exposure because GBL is a small, water‑miscible molecule that is absorbed and readily metabolised to GHB after systemic uptake, so exposure score is 1 for pregnancy (adult topical). Sources: ECHA substance page; SDSs/regulatory summaries; CDC/FDA reviews of ingestion risks.
- butyrolactone é seguro durante a amamentação?
- No authoritative reproductive/breastfeeding safety assessment (CIR/SCCS/harmonised CLP) flagging developmental or lactation hazards. Systemic exposure from topical use is expected to be low but measurable in adults; because GBL converts to GHB systemically, breastmilk transfer would only be a concern if significant maternal systemic levels occur (not typical from normal cosmetic topical use). Thus hazard/mechanism remain 0; exposure scored 1 (low but measurable). Sources: ECHA substance information; LactMed/GHB references and FDA/CDC warnings about systemic effects from ingestion rather than topical use.
- butyrolactone é seguro para a pele do bebê?
- No infant‑specific reproductive/developmental toxicity evidence from authoritative cosmetic safety bodies. Per scoring rules, because adult topical exposure is scored as 1 (measurable), infant skin exposure is increased by +1 (immature barrier and higher SA:BW) to give e=2 (moderate). There is no infant‑specific data showing placental or dermal developmental hazards; the main concern in literature is systemic GHB effects after ingestion/large exposures, not routine topical cosmetic use. Sources: ECHA substance page; EPA/EPA inert reassessment and SDSs describing routes of concern (ingestion/systemic), and EWG ingredient entry.
- Como o VeriMom pontua butyrolactone?
- O VeriMom pontua butyrolactone em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a butyrolactone na gravidez?
- Veja nossa lista curada de alternativas seguras a butyrolactone com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.